Hypertension, Vol 19, 567-574, Copyright © 1992 by American Heart Association
M Pirpiris, K Sudhir, S Yeung, G Jennings and JA Whitworth
In previous studies short-term cortisol increased cold pressor responses
and the rise in forearm vascular resistance accompanying intra-arterial
norepinephrine without an increase in overall resting sympathetic nervous
activity. The present study examined whether these alterations in pressor
response are glucocorticoid or mineralocorticoid effects, or both. Normal
male subjects (n = 12) received either fludrocortisone, 0.3 mg daily (n =
6), or dexamethasone, 3 mg daily (n = 6), for 7 days. Hemodynamic studies
were performed before and on day 7 of treatment. Fludrocortisone increased
body weight from 69.3 +/- 1.8 to 71.1 +/- 2 kg (p less than 0.001), cardiac
output from 5.0 to 6.0 l/min (+/- 0.1, p less than 0.01), mean arterial
pressure from 82 +/- 1 to 91 +/- 1 mm Hg (p less than 0.001), cold pressor
responsiveness from 13.0 to 39.0 mm Hg/ml per 100 ml per minute (R units)
(+/- 4.3, p less than 0.01), and forearm vascular response to
intra-arterial norepinephrine (F = 59.4, p less than 0.01) and angiotensin
II (F = 30.8, p less than 0.01) infusions. Total peripheral resistance fell
from 22.0 to 20.1 mm Hg/l per minute (+/- 0.3, p less than 0.05).
Dexamethasone did not increase cardiac output, 5.1 to 5.2 l/min (+/- 0.1),
or body weight but did increase mean arterial pressure from 82 +/- 3 to 91
+/- 3 mm Hg (p less than 0.001), cold pressor responsiveness from 8.6 to
17.1 R units (+/- 2.8, p less than 0.05), and forearm vascular response to
intra-arterial norepinephrine (F = 33.0, p less than 0.01) and angiotensin
II (F = 54.9, p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Pressor responsiveness in corticosteroid-induced hypertension in humans
Department of Nephrology, Royal Melbourne Hospital, Australia.
This article has been cited by other articles:
![]() |
B. Chamarthi, N. S. Kolatkar, S. C. Hunt, J. S. Williams, E. W. Seely, N. J. Brown, L. J. Murphey, X. Jeunemaitre, and G. H. Williams Urinary Free Cortisol: An Intermediate Phenotype and a Potential Genetic Marker for a Salt-Resistant Subset of Essential Hypertension J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1340 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Brotman, J. P. Girod, M. J. Garcia, J. V. Patel, M. Gupta, A. Posch, S. Saunders, G. Y. H. Lip, S. Worley, and S. Reddy Effects of Short-Term Glucocorticoids on Cardiovascular Biomarkers J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3202 - 3208. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Girod and D. J. Brotman Does altered glucocorticoid homeostasis increase cardiovascular risk? Cardiovasc Res, November 1, 2004; 64(2): 217 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Di Filippo, F. Rossi, E. Ongini, P. Del Soldato, M. Perretti, and M. D'Amico The Distinct Alterations Produced in Cardiovascular Functions by Prednisolone and Nitro-prednisolone (NCX-1015) in the Rat Highlight a Causal Role for Endothelin-1 J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1133 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Liu, S. Schmuck, J. Z. Chorazcyzewski, R. Gros, and R. D. Feldman Aldosterone Regulates Vascular Reactivity: Short-Term Effects Mediated by Phosphatidylinositol 3-Kinase-Dependent Nitric Oxide Synthase Activation Circulation, November 11, 2003; 108(19): 2400 - 2406. [Abstract] [Full Text] [PDF] |
||||
![]() |
K E Warnes, C L Coulter, J S Robinson, and I C McMillen The effect of intrafetal infusion of metyrapone on arterial blood pressure and on the arterial blood pressure response to angiotensin II in the sheep fetus during late gestation J. Physiol., October 15, 2003; 552(2): 621 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Goldstein, S. Pechnik, C. Holmes, B. Eldadah, and Y. Sharabi Association Between Supine Hypertension and Orthostatic Hypotension in Autonomic Failure Hypertension, August 1, 2003; 42(2): 136 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Scheuer and A. G. Bechtold Glucocorticoids potentiate central actions of angiotensin to increase arterial pressure Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1719 - R1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Scheuer and S. W. Mifflin Glucocorticoids modulate baroreflex control of renal sympathetic nerve activity Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1440 - R1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hatakeyama, S. Inaba, N. Taniguchi, and I. Miyamori Functional Adrenocorticotropic Hormone Receptor in Cultured Human Vascular Endothelial Cells : Possible Role in Control of Blood Pressure Hypertension, November 1, 2000; 36(5): 862 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dodt, B. Keyser, M. Molle, H. L. Fehm, and M. Elam Acute Suppression of Muscle Sympathetic Nerve Activity by Hydrocortisone in Humans Hypertension, March 1, 2000; 35(3): 758 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E Ullian The role of corticosteroids in the regulation of vascular tone Cardiovasc Res, January 1, 1999; 41(1): 55 - 64. [Full Text] [PDF] |
||||
![]() |
M. E. Ullian, D. J. Hazen-Martin, L. G. Walsh, R. K. Davda, and B. M. Egan Carbenoxolone Damages Endothelium and Enhances Vasoconstrictor Action in Aortic Rings Hypertension, June 1, 1996; 27(6): 1346 - 1352. [Abstract] [Full Text] |
||||
![]() |
M. E. Ullian and L. G. Walsh Corticosterone Metabolism and Effects on Angiotensin II Receptors in Vascular Smooth Muscle Circ. Res., October 1, 1995; 77(4): 702 - 709. [Abstract] [Full Text] |
||||
![]() |
C. N. May and J. A. Bednarik Regional Hemodynamic and Endocrine Effects of Aldosterone and Cortisol in Conscious Sheep : Comparison With the Effects of Corticotropin Hypertension, August 1, 1995; 26(2): 294 - 300. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |